<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An 11-year-old female felt discomfort in her head, and left hemispheric syndrome occurred shortly thereafter </plain></SENT>
<SENT sid="1" pm="."><plain>At presentation, her National Institutes of Health <z:hpo ids='HP_0001297'>stroke</z:hpo> scale (NIHSS) score was 13, and a magnetic resonance imaging scan revealed <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0751955" disease_type="Disease or Syndrome" abbrv="">brain infarction</z:e> in the left thalamus </plain></SENT>
<SENT sid="2" pm="."><plain>She was immediately treated with the intravenous administration of tissue plasminogen activator (IV t-PA) followed by <z:chebi fb="0" ids="31530">edaravone</z:chebi>, a free radical scavenger </plain></SENT>
<SENT sid="3" pm="."><plain>Two hours after IV t-PA, her symptoms dramatically resolved and her NIHSS score decreased to 5 </plain></SENT>
<SENT sid="4" pm="."><plain>No adverse events were observed </plain></SENT>
<SENT sid="5" pm="."><plain>She was the youngest patient treated with IV t-PA in Japan, and would be the youngest treated in most developed countries </plain></SENT>
<SENT sid="6" pm="."><plain>An optimal treatment for <z:hpo ids='HP_0001297'>stroke</z:hpo> in children has not been established, and this case highlights the urgent need to examine the safety and efficacy of IV t-PA and <z:chebi fb="0" ids="31530">edaravone</z:chebi> therapy for <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in children </plain></SENT>
</text></document>